Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy.

Voelker J, Berg PH, Sheetz M, Duffin K, Shen T, Moser B, Greene T, Blumenthal SS, Rychlik I, Yagil Y, Zaoui P, Lewis JB.

J Am Soc Nephrol. 2017 Mar;28(3):953-962. doi: 10.1681/ASN.2015111230. Epub 2016 Sep 19.

PMID:
27647855
2.

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group..

Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12.

PMID:
26087670
3.

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

Umanath K, Jalal DI, Greco BA, Umeukeje EM, Reisin E, Manley J, Zeig S, Negoi DG, Hiremath AN, Blumenthal SS, Sika M, Niecestro R, Koury MJ, Ma KN, Greene T, Lewis JB, Dwyer JP; Collaborative Study Group..

J Am Soc Nephrol. 2015 Oct;26(10):2578-87. doi: 10.1681/ASN.2014080842. Epub 2015 Mar 3.

4.

Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Lewis JB, Sika M, Koury MJ, Chuang P, Schulman G, Smith MT, Whittier FC, Linfert DR, Galphin CM, Athreya BP, Nossuli AK, Chang IJ, Blumenthal SS, Manley J, Zeig S, Kant KS, Olivero JJ, Greene T, Dwyer JP; Collaborative Study Group..

J Am Soc Nephrol. 2015 Feb;26(2):493-503. doi: 10.1681/ASN.2014020212. Epub 2014 Jul 24.

5.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators..

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

6.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators..

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
7.

Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.

Dwyer JP, Sika M, Schulman G, Chang IJ, Anger M, Smith M, Kaplan M, Zeig S, Koury MJ, Blumenthal SS, Lewis JB; Collaborative Study Group..

Am J Kidney Dis. 2013 May;61(5):759-66. doi: 10.1053/j.ajkd.2012.11.041. Epub 2013 Jan 29.

PMID:
23369827
8.

How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?

Proschan M, Ford CE, Cutler JA, Graumlich JF, Pavlik V, Cushman WC, Davis BR, Alderman MH, Gordon D, Furberg CD, Franklin SS, Blumenthal SS, Castaldo RS, Preston RA; LHAT Collaborative Research Group..

Stat Med. 2013 Feb 28;32(5):884-97. doi: 10.1002/sim.5580. Epub 2012 Sep 7.

PMID:
22961832
9.

Characterization of a 65 kDa NIF in the nuclear matrix of the monocot Allium cepa that interacts with nuclear spectrin-like proteins.

Pérez-Munive C, Blumenthal SS, de la Espina SM.

Cell Biol Int. 2012;36(12):1097-105. doi: 10.1042/CBI20120237.

PMID:
22950797
10.

Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuria.

Korbet SM, Lewis EJ; Collaborative Study Group..

Nephrol Dial Transplant. 2012 Jul;27(7):2813-9. doi: 10.1093/ndt/gfr741. Epub 2011 Dec 23.

PMID:
22199359
11.

Evolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward.

Blumenthal SS.

Postgrad Med. 2011 Nov;123(6):166-79. doi: 10.3810/pgm.2011.11.2506. Review.

PMID:
22104465
12.

Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats.

Tabatabai NM, Sharma M, Blumenthal SS, Petering DH.

Diabetes Res Clin Pract. 2009 Jan;83(1):e27-30. doi: 10.1016/j.diabres.2008.11.003. Epub 2008 Dec 17.

13.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators., Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

14.

The prognosis and pathogenesis of severe lupus glomerulonephritis.

Schwartz MM, Korbet SM, Lewis EJ; Collaborative Study Group..

Nephrol Dial Transplant. 2008 Apr;23(4):1298-306. Epub 2007 Nov 28.

PMID:
18045825
15.
16.

Biochemical and immunological characterization of pea nuclear intermediate filament proteins.

Blumenthal SS, Clark GB, Roux SJ.

Planta. 2004 Apr;218(6):965-75. Epub 2004 Jan 15.

PMID:
14727112
17.

Mouse kidney expresses mRNA of four highly related sodium-glucose cotransporters: regulation by cadmium.

Tabatabai NM, Blumenthal SS, Lewand DL, Petering DH.

Kidney Int. 2003 Oct;64(4):1320-30.

18.

Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium.

Tabatabai NM, Blumenthal SS, Lewand DL, Petering DH.

Toxicol Appl Pharmacol. 2001 Dec 15;177(3):163-73.

PMID:
11749115
19.

Spectrin-like proteins in plant nuclei.

De Ruijter NC, Ketelaar T, Blumenthal SS, Emons AM, Schel JH.

Cell Biol Int. 2000;24(7):427-38.

PMID:
10875890
20.

Cadmium decreases SGLT1 messenger RNA in mouse kidney cells.

Blumenthal SS, Ren L, Lewand DL, Krezoski SK, Petering DH.

Toxicol Appl Pharmacol. 1998 Mar;149(1):49-54.

PMID:
9512726

Supplemental Content

Loading ...
Support Center